Accelerating Genome Editing in CHO Cells Using CRISPR Cas9 and CRISPy, a Web-Based Target Finding Tool

Chinese hamster ovary (CHO) cells are widely used in the biopharmaceutical industry as a host for the production of complex pharmaceutical proteins. Thus genome engineering of CHO cells for improved product quality and yield is of great interest. Here, we demonstrate for the first time the efficacy of the CRISPR Cas9 technology in CHO cells by generating site‐specific gene disruptions in COSMC and FUT8, both of which encode proteins involved in glycosylation. The tested single guide RNAs (sgRNAs) created an indel frequency up to 47.3% in COSMC, while an indel frequency up to 99.7% in FUT8 was achieved by applying lectin selection. All eight sgRNAs examined in this study resulted in relatively high indel frequencies, demonstrating that the Cas9 system is a robust and efficient genome‐editing methodology in CHO cells. Deep sequencing revealed that 85% of the indels created by Cas9 resulted in frameshift mutations at the target sites, with a strong preference for single base indels. Finally, we have developed a user‐friendly bioinformatics tool, named “CRISPy” for rapid identification of sgRNA target sequences in the CHO‐K1 genome. The CRISPy tool identified 1,970,449 CRISPR targets divided into 27,553 genes and lists the number of off‐target sites in the genome. In conclusion, the proven functionality of Cas9 to edit CHO genomes combined with our CRISPy database have the potential to accelerate genome editing and synthetic biology efforts in CHO cells. Biotechnol. Bioeng. 2014; 111: 1604–1616. © 2014 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.

[1]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[2]  Nathan E Lewis,et al.  The emerging CHO systems biology era: harnessing the 'omics revolution for biotechnology. , 2013, Current opinion in biotechnology.

[3]  Mike Boxem,et al.  CRISPR/Cas9-Targeted Mutagenesis in Caenorhabditis elegans , 2013, Genetics.

[4]  Weiguo Zheng,et al.  A Guide RNA Sequence Design Platform for the CRISPR/Cas9 System for Model Organism Genomes , 2013, BioMed research international.

[5]  Bing Yang,et al.  Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice , 2013, Nucleic acids research.

[6]  Elizabeth Pennisi,et al.  The CRISPR craze. , 2013, Science.

[7]  R. Jaenisch,et al.  One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[8]  Melissa M. Harrison,et al.  Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease , 2013, Genetics.

[9]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[10]  Edward J. O'Brien,et al.  Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome , 2013, Nature Biotechnology.

[11]  Chris P. Ponting,et al.  Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System , 2013, Cell reports.

[12]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[13]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[14]  Xiaojun Zhu,et al.  Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos , 2013, Cell Research.

[15]  George M. Church,et al.  Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems , 2013, Nucleic acids research.

[16]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[17]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[18]  Seung Woo Cho,et al.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.

[19]  Jennifer Doudna,et al.  RNA-programmed genome editing in human cells , 2013, eLife.

[20]  Jeffry D. Sander,et al.  Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.

[21]  Dana Carroll,et al.  A CRISPR approach to gene targeting. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[23]  Jian Ye,et al.  Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction , 2012, BMC Bioinformatics.

[24]  Kelvin H. Lee,et al.  Chinese hamster genome database: an online resource for the CHO community at www.CHOgenome.org. , 2012, Biotechnology and bioengineering.

[25]  H. Wandall,et al.  Mining the O-glycoproteome using zinc-finger nuclease–glycoengineered SimpleCell lines , 2011, Nature Methods.

[26]  Kyle A. Barlow,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[27]  Jeffrey C. Miller,et al.  Highly efficient deletion of FUT8 in CHO cell lines using zinc‐finger nucleases yields cells that produce completely nonfucosylated antibodies , 2010, Biotechnology and bioengineering.

[28]  B. Xia,et al.  Cosmc is an essential chaperone for correct protein O-glycosylation , 2010, Proceedings of the National Academy of Sciences.

[29]  Morten H. H. Nørholm A mutant Pfu DNA polymerase designed for advanced uracil-excision DNA engineering , 2010, BMC biotechnology.

[30]  Yolanda Santiago,et al.  BAK and BAX deletion using zinc‐finger nucleases yields apoptosis‐resistant CHO cells , 2010, Biotechnology and bioengineering.

[31]  P. Duchateau,et al.  Targeted approaches for gene therapy and the emergence of engineered meganucleases , 2009, Expert opinion on biological therapy.

[32]  Bartek Wilczynski,et al.  Biopython: freely available Python tools for computational molecular biology and bioinformatics , 2009, Bioinform..

[33]  A. Klug,et al.  Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases , 2008, Proceedings of the National Academy of Sciences.

[34]  Katie F Wlaschin,et al.  Recombinant protein therapeutics from CHO cells : 20 years and counting , 2007 .

[35]  Morten H. H. Nørholm,et al.  Advancing uracil-excision based cloning towards an ideal technique for cloning PCR fragments , 2006, Nucleic acids research.

[36]  Kazuya Yamano,et al.  Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. , 2004, Biotechnology and bioengineering.

[37]  Shigeru Iida,et al.  Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.

[38]  K. Shitara,et al.  Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma , 2004, Cancer Research.

[39]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[40]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[41]  Eiji Miyoshi,et al.  The α1-6-fucosyltransferase gene and its biological significance , 1999 .

[42]  D Williams,et al.  The control of glycoprotein synthesis: N-acetylglucosamine linkage to a mannose residue as a signal for the attachment of L-fucose to the asparagine-linked N-acetylglucosamine residue of glycopeptide from alpha1-acid glycoprotein. , 1976, Biochemical and biophysical research communications.

[43]  M. Boxem,et al.  CRISPR/Cas9-targeted mutagenesis in C. elegans , 2013 .

[44]  H. J. Genee,et al.  Adaptive evolution of drug targets in producer and non-producer organisms. , 2012, The Biochemical journal.

[45]  Y. Ikeda,et al.  The alpha1-6-fucosyltransferase gene and its biological significance. , 1999, Biochimica et biophysica acta.

[46]  P. Sharp,et al.  Positive genetic selection for gene disruption in mammalian cells by homologous recombination. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Supplement To: the Genomic Sequence of the Chinese Hamster Ovary (cho)-k1 Cell Line , 2022 .